Am. J. Respir. Cell Mol. Biol., Vol 17, No. 2, 08 1997, 235-242.
Differential regulation of human, antigen-specific Th1 and Th2 responses by the B-7 homologues, CD80 and CD86
GG Bashian, CM Braun, SK Huang, A Kagey-Sobotka, LM Lichtenstein and DM Essayan
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
A selectivity of B7.1 (CD80) for promoting Th1 responses and B7.2 (CD86)
for promoting Th2 responses in the murine system has recently been
suggested. The present study explores this hypothesis, using human PBMCs
and antigen-specific Th1 and Th2 clones. Proliferative responses of
peripheral blood mononuclear cells (PBMCs) from ragweed-allergic, tetanus
toxoid-immunized individuals were downregulated by treatment with anti-CD86
in ragweed- and tetanus toxoid-driven cultures (% Inhibition = 55 +/- 4 and
61 +/- 12, respectively; P < 0.03 relative to untreated cultures). Gene
expression in PBMCs for interleukin (IL)-4, IL-5, and interferon gamma
(IFNgamma), assessed by reverse- transcriptase polymerase chain reaction,
was also downregulated by treatment with anti-CD86 in both the ragweed- and
tetanus toxoid-driven systems. Neither independent efficacy nor synergy
with anti-CD86 was apparent with anti-CD80 treatment; two different
anti-CD80 blocking antibodies yielded identical results. Conversely,
antigen-specific Th1 and Th2 clones were insensitive to treatment with
either anti-CD80, anti-CD86, or a combination of the two. Unaffected
parameters included proliferative response (P < 0.14 and 0.33,
respectively, for Th1 and Th2), proinflammatory cytokine gene expression,
and cytokine protein secretion into culture supernatants (P < 0.44 and
0.16, respectively, for IL-4 and IFNgamma). We conclude that CD86 is the
primary B7 signaling homologue in human PBMC responses, and that second
signal pathways through the B7 homologues have no effect on phenotypically
differentiated T helper cells in humans.
This article has been cited by other articles:

|
 |

|
 |
 
T. J. Corydon, A. Haagerup, T. G. Jensen, H. G. Binderup, M. S. Petersen, K. Kaltoft, J. Vestbo, T. A. Kruse, and A. D. Borglum
A functional CD86 polymorphism associated with asthma and related allergic disorders
J. Med. Genet.,
August 1, 2007;
44(8):
509 - 515.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. I. Brodskyn, G. K. DeKrey, and R. G. Titus
Influence of Costimulatory Molecules on Immune Response to Leishmania major by Human Cells In Vitro
Infect. Immun.,
February 1, 2001;
69(2):
665 - 672.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. T. LEONARD, P. M. SOCCAL, L. SINGER, G. J. BERRY, J. THEODORE, P. G. HOLT, R. L. DOYLE, and G. D. ROSEN
Dendritic Cells and Macrophages in Lung Allografts . A Role in Chronic Rejection?
Am. J. Respir. Crit. Care Med.,
April 1, 2000;
161(4):
1349 - 1354.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Z. H. Jaffar, L. Stanciu, A. Pandit, J. Lordan, S. T. Holgate, and K. Roberts
Essential Role for Both CD80 and CD86 Costimulation, But Not CD40 Interactions, in Allergen-Induced Th2 Cytokine Production from Asthmatic Bronchial Tissue: Role for {alpha}{beta}, But Not {gamma}{delta}, T Cells
J. Immunol.,
December 1, 1999;
163(11):
6283 - 6291.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E Burastero and G. A Rossi
Immunomodulation by interference with co-stimulatory molecules: therapeutic perspectives in asthma
Thorax,
June 1, 1999;
54(6):
554 - 557.
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Larche, S. J. Till, B. M. Haselden, J. North, J. Barkans, C. J. Corrigan, A. B. Kay, and D. S. Robinson
Costimulation Through CD86 Is Involved in Airway Antigen-Presenting Cell and T Cell Responses to Allergen in Atopic Asthmatics
J. Immunol.,
December 1, 1998;
161(11):
6375 - 6382.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 American Thoracic Society.
|
|
|